Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
32.53
-0.29 (-0.88%)
At close: May 01, 2025, 2:41 PM
Royalty Pharma Revenue
Royalty Pharma reported an annual revenue of $2.26B, reflecting a -3.85% growth. For the quarter ending December 31, 2024, Royalty Pharma generated $594M in revenue.
Revenue (ttm)
$2.26B
Revenue Growth
-3.85%
Price / Sales Ratio
5.04
Revenue / Employee
$30.19M
Employees
75
Market Cap
14.1B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.26B | -3.85% |
| Dec 31, 2023 | 2.35B | +5.24% |
| Dec 31, 2022 | 2.24B | -2.28% |
| Dec 31, 2021 | 2.29B | +7.89% |
| Dec 31, 2020 | 2.12B | n/a |